NEW YORK (GenomeWeb) — The Mayo Clinic last week announced that it will offer a test based on Ion Torrent's AmpliSeq V2 cancer hotspot panel through its CLIA-certified Next-Generation Sequencing Lab, a move that the clinic expects will routinize use of the 50-gene panel in the care of patients with a variety of solid tumors.

The AmpliSeq panel test, called CANCP, joins just one other NGS test, a 17-gene hereditary colon cancer assay, offered through the CLIA lab to Mayo physicians and to providers worldwide through the clinic's Mayo Medical Laboratories.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.